2021-01-08,Spero Therapeutics (NASDAQ:SPRO) Shareholders Booked A 87% Gain In The Last Year
2020-12-17,Spero Therapeutics Announces Appointment of Sath Shukla as Chief Financial Officer
2020-12-16,Spero Therapeutics Added to the NASDAQ Biotechnology Index
2020-12-11,Is SPRO A Good Stock To Buy Now?
2020-12-10,Spero Therapeutics Announces First Patient Dosed with SPR720 in Phase 2a Clinical Trial in Patients with Nontuberculous Mycobacterial Pulmonary Disease
2020-12-02,Spero Therapeutics Announces Appointment of Tamara Joseph as Chief Legal Officer
2020-11-30,Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-11-30,"Spero Therapeutics to Present at the Evercore ISI HealthCONx Conference on December 3, 2020"
2020-11-09,"Spero Therapeutics, Inc. (NASDAQ:SPRO) Analysts Are Pretty Bullish On The Stock After Recent Results"
2020-11-07,"Spero Therapeutics, Inc. (SPRO) Q3 2020 Earnings Call Transcript"
2020-11-05,Spero Therapeutics Announces Third Quarter 2020 Operating Results and Provides Business Update
2020-11-05,"Spero Therapeutics, Inc. to Host Earnings Call"
2020-11-03,Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-10-30,"Are Institutions Heavily Invested In Spero Therapeutics, Inc.'s (NASDAQ:SPRO) Shares?"
2020-10-26,5 Healthcare Stocks the Experts at Aquilo Capital Management Are Buying (1 Has Gained 88% This Month)
2020-10-16,Spero Therapeutics to Present Data for All Pipeline Programs at IDWeek 2020
2020-09-30,Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-09-30,Spero Therapeutics (SPRO) Catches Eye: Stock Jumps 7%
2020-09-24,Spero Therapeutics Hosting Key Opinion Leader Call on Oral Tebipenem HBr for the Treatment of Complicated Urinary Tract Infections
2020-09-15,Spero Therapeutics to Present at Investor Conferences in September
2020-09-11,Why Spero Therapeutics Shares Are Sliding Today
2020-09-11,Spero Therapeutics Announces Pricing of Securities Offering
2020-09-09,Spero Therapeutics Announces Proposed Public Offering
2020-09-08,Spero Therapeutics Announces Positive Topline Results from its Phase 3 ADAPT-PO Clinical Trial of Oral Tebipenem HBr in Complicated Urinary Tract Infection and Acute Pyelonephritis
2020-09-01,Spero's (SPRO) IND Accepted by FDA for Pulmonary Disease Drug
2020-08-31,We're Keeping An Eye On Spero Therapeutics' (NASDAQ:SPRO) Cash Burn Rate
2020-08-31,Spero Therapeutics Announces FDA Acceptance of IND Application for SPR720
2020-08-06,"Spero Therapeutics, Inc. (SPRO) Reports Q2 Loss, Lags Revenue Estimates"
2020-08-06,Spero Therapeutics Announces Second Quarter 2020 Operating Results and Provides Business Update
2020-07-31,Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-07-30,"Analysts Estimate Spero Therapeutics, Inc. (SPRO) to Report a Decline in Earnings: What to Look Out for"
2020-07-29,"Spero Therapeutics to Provide Business Update and Report Second Quarter 2020 Financial Results on Thursday, August 6, 2020"
2020-06-30,Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-06-17,"Spero Investor Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Spero Therapeutics, Inc. To Contact The Firm"
2020-06-14,"Is Spero Therapeutics, Inc. (SPRO) Going to Burn These Hedge Funds?"
2020-06-08,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spero Therapeutics, Inc. - SPRO"
2020-06-04,"Spero Investor Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Spero Therapeutics, Inc. To Contact The Firm"
2020-06-03,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spero Therapeutics, Inc. - SPRO"
2020-06-02,"10 Tax Tips for Airbnb, HomeAway & VRBO Vacation Rentals"
2020-06-01,"SPERO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Spero Therapeutics, Inc. To Contact The Firm"
2020-06-01,Spero Therapeutics to Present at the Jefferies 2020 Virtual Healthcare Conference
2020-06-01,Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-05-28,"SPERO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Spero Therapeutics, Inc. To Contact The Firm"
2020-05-27,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of  Spero Therapeutics, Inc. - SPRO"
2020-05-25,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spero Therapeutics, Inc. - SPRO"
2020-05-13,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of  Spero Therapeutics, Inc. - SPRO"
2020-05-12,"SPRO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Spero Therapeutics, Inc. and Encourages Investors to Contact the Firm"
2020-05-12,"Spero Therapeutics, Inc. (SPRO) Q1 2020 Earnings Call Transcript"
2020-05-12,"Spero Therapeutics, Inc. (SPRO) Shares March Higher, Can It Continue?"
2020-05-11,H.C. Wainwright Sticks to Their Buy Rating for Spero Therapeutics Inc
2020-05-08,"Spero Therapeutics Inc (SPRO) Reports Q1 Loss, Misses Revenue Estimates"
2020-05-08,Spero Therapeutics Announces First Quarter 2020 Operating Results and Provides Business Update
2020-05-05,Spero Therapeutics Completes Patient Enrollment in Pivotal Phase 3 Clinical Trial (ADAPT-PO) of Oral Tebipenem HBr versus Intravenous Ertapenem for the Treatment of Complicated Urinary Tract Infection
2020-05-04,"Spero Therapeutics to Provide Business Update and Report First Quarter 2020 Financial Results on Friday, May 8, 2020"
2020-04-30,Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-04-16,Spero Announces Appointment of Scott Jackson to its Board of Directors
2020-03-31,Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-03-18,"Spero Therapeutics, Inc. Yearly Results Just Came Out: Here's What Analysts Are Forecasting For Next Year"
2020-03-16,"Spero Therapeutics, Inc. (SPRO) Reports Q4 Loss, Tops Revenue Estimates"
2020-03-16,Spero Therapeutics Announces Fourth Quarter and Full-Year 2019 Operating Results and Provides Pipeline Update
2020-03-11,Spero Therapeutics Receives FDA Orphan Drug Designation for SPR720 for the Treatment of Nontuberculous Mycobacterial (NTM) Infection
2020-03-05,Spero Therapeutics Announces Closing of Rights Offering
2020-03-05,"Earnings Preview: Spero Therapeutics, Inc. (SPRO) Q4 Earnings Expected to Decline"
2020-02-28,Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-02-26,Spero Therapeutics to Present at March Investor Conferences
2020-02-11,Spero Therapeutics Announces Commencement of Rights Offering
2020-02-05,Spero Therapeutics Announces Exercise of $15.9 Million Option by BARDA for Tebipenem HBr Development
2020-01-31,Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-01-30,Spero Therapeutics Announces Proposed Rights Offering
2020-01-16,"Introducing Spero Therapeutics (NASDAQ:SPRO), A Stock That Climbed 11% In The Last Year"
2020-01-13,Spero Reports Preliminary Findings from Phase 1 Clinical Trial of SPR206 and Plans to Advance Program with Alliance Partners Everest Medicines and the Department of Defense
2019-12-29,"Week Ahead In Biotech: PDUFA Date Ahead For Astra Zeneca, Merck's Lynparza, Pending Clinical Readouts In Focus"
2019-12-17,"Here is What Hedge Funds Think About Spero Therapeutics, Inc. (SPRO)"
2019-12-12,Iterum Down as Sulopenem Antibiotic Fails in Phase III Study
2019-12-05,Spero Posts Preliminary Data on SPR720 for Pulmonary Disease
2019-12-04,Spero Reports Preliminary Findings from Phase 1 Clinical Trial of SPR720 and Announces Plans to Advance Program into Proof-of-Concept Clinical Trial in Patients with NTM Pulmonary Disease
2019-11-29,Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2019-11-26,Spero Therapeutics to Host Key Opinion Leader Symposium in December
2019-11-04,"Spero Therapeutics, Inc. (SPRO) Reports Q3 Loss, Tops Revenue Estimates"
2019-11-04,Spero Therapeutics Announces Third Quarter 2019 Operating Results and Provides Pipeline Review
2019-10-31,Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2019-10-23,"How Many Spero Therapeutics, Inc. (NASDAQ:SPRO) Shares Do Institutions Own?"
2019-10-03,Spero Therapeutics Announces Positive Recommendation to Continue Phase 3 Clinical Trial of SPR994 as Planned Following Independent Review Committee Analysis of SPR994 Treated Patients in Lead-in Cohort of Trial
2019-09-30,Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2019-09-26,Spero Therapeutics Announces Presentations at IDWeek 2019
2019-08-08,"Spero Therapeutics, Inc. (SPRO) Reports Q2 Loss, Misses Revenue Estimates"
2019-08-08,Spero Therapeutics Announces Second Quarter 2019 Operating Results and Provides Pipeline Update
2019-08-01,"Spero Therapeutics, Inc. (SPRO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release"
2019-07-16,Spero Therapeutics Announces $5.9 Million Award from U.S. Department of Defense to Further Clinical Development of SPR206
2019-07-11,Did Changing Sentiment Drive Spero Therapeutics's (NASDAQ:SPRO) Share Price Down By 15%?
2019-06-28,Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2019-06-20,Spero Therapeutics Announces Collaboration with Bill & Melinda Gates Medical Research Institute to Develop SPR720 for Tuberculosis
2019-06-17,Spero Therapeutics to Present Data for All Pipeline Programs at the ASM Microbe 2019 Conference
2019-06-13,Spero Announces $10 Million Registered Direct Offering of Common Stock
2019-05-31,Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2019-05-09,"Spero Therapeutics, Inc. (SPRO) Reports Q1 Loss, Tops Revenue Estimates"
2019-05-09,Spero Therapeutics Announces First Quarter 2019 Operating Results and Provides Pipeline Review
2019-05-02,Expedia Shares Fall as Home-Rental Business Vrbo Goes Slow
2019-05-02,"Analysts Estimate Spero Therapeutics, Inc. (SPRO) to Report a Decline in Earnings: What to Look Out for"
2019-05-01,Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
